Market

Covid treatment firm poised to float on London Stock Exchange


Life sciences group that has developed treatment to kill Covid with laser light will become latest firm to list in London when it goes public










A life sciences group that has developed a treatment to kill Covid with laser light will become the latest firm to list in London when it goes public today. 

Ondine Biomedical will join the junior market in a £104m float. It hopes to raise around £23m to help roll out its first product. 

Innovation: Ondine's treatment destroys viruses – including Covid – bacteria, yeasts and fungi within minutes.

Innovation: Ondine’s treatment destroys viruses – including Covid – bacteria, yeasts and fungi within minutes.

This is a treatment that destroys viruses – including Covid – bacteria, yeasts and fungi within minutes. 

It works by a medical professional applying a ‘photodisinfection’ liquid into the nose – a key area for viruses to breed – and then illuminating it with a laser light, killing the pathogens in the process. 

The Canadian company’s float comes as AIM has had its best year since 2006 – with more than 60 companies joining. 

The technology Ondine uses was developed at Imperial College London and the group believes the stock market in the City has a better understanding of healthcare firms than Toronto. 



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.